يعرض 1 - 17 نتائج من 17 نتيجة بحث عن '"Jaiswal, Shyam K"', وقت الاستعلام: 0.48s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Int J Stroke ; ISSN:1747-4949

  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
    Academic Journal
  7. 7
  8. 8
  9. 9
    Academic Journal

    وصف الملف: application/pdf

    Relation: Fearon, Conor; Rawal, Sapna; Olszewska, Diana; Alcaide-Leon, Paula; Kern, Drew S.; Sharma, Soumya; Jaiswal, Shyam K.; Murthy, Jagarlapudi M.K.; Ha, Ainhi D.; Schwartz, Raymond S.; Fung, Victor S.C.; Spears, Chauncey; Tholanikunnel, Tracy; Almeida, Leonardo; Hatano, Taku; Oji, Yutaka; Hattori, Nobutaka; Shubham, Shantanu; Kumar, Hrishikesh; Bhidayasiri, Roongroj; Laohathai, Christopher; Lang, Anthony E. (2022). "Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired Disorders." Movement Disorders Clinical Practice 9(3): 311-325.; https://hdl.handle.net/2027.42/171975; Movement Disorders Clinical Practice; Video Tournament. A case of progressive gait imbalance. Presented at: June 4, 2021; 7th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress.; Gaig C, Graus F, Compta Y, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology 2017; 88 ( 18 ): 1736 – 1743. https://doi.org/10.1212/WNL.0000000000003887.; Sharma P, Garg RK, Somvanshi DS, Malhotra HS. Progressive supranuclear palsy like syndrome: neurocysticercosis an unusual cause. Neurol India 2011; 59 ( 3 ): 484 – 485. https://doi.org/10.4103/0028-3886.82763.; Filley CM, Halliday W, Kleinschmidt-DeMasters BK. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 2004; 63 ( 1 ): 1 – 12. https://doi.org/10.1093/jnen/63.1.1.; Aydin K, Sencer S, Demir T, Ogel K, Tunaci A, Minareci O. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol 2002; 23 ( 7 ): 1173 – 1179.; Kobayashi M. Marked asymmetry of white matter lesions caused by chronic toluene exposure. Neurol Sci 2014; 35 ( 3 ): 495 – 497. https://doi.org/10.1007/s10072-013-1581-8.; Lin CM, Liu CK. Reversible cerebral periventricular white matter changes with corpus callosum involvement in acute toluene-poisoning. J Neuroimaging 2015; 25 ( 3 ): 497 – 500. https://doi.org/10.1111/jon.12155.; Ramcharan K, Ramesar A, Ramdath M, Teelucksingh J, Gosein M. Encephalopathy and neuropathy due to glue, paint thinner, and gasoline sniffing in Trinidad and Tobago-MRI findings. Case Rep Neurol Med 2014; 2014: 850109. https://doi.org/10.1155/2014/850109.; Ikeda M, Tsukagoshi H. Encephalopathy due to toluene sniffing. Report of a case with magnetic resonance imaging. Eur Neurol 1990; 30 ( 6 ): 347 – 349. https://doi.org/10.1159/000117371.; Hirai H, Ikeuchi Y. MRI of chronic toluene intoxication. Rinsho Shinkeigaku 1993; 33 ( 5 ): 552 – 555.; Terashi H, Nagata K, Satoh Y, Hirata Y, Hatazawa J. Hippocampal hypoperfusion underlying dementia due to chronic toluene intoxication. Rinsho Shinkeigaku 1997; 37 ( 11 ): 1010 – 1013.; Sakai T, Honda S, Kuzuhara S. Encephalomyelopathy demonstrated on MRI in a case of chronic toluene intoxication. Rinsho Shinkeigaku 2000; 40 ( 6 ): 571 – 575.; Kojima S, Hirayama K, Furumoto H, Fukutake T, Hattori T. Magnetic resonance imaging in chronic toluene abuse, and volitional hyperkinesia. Rinsho Shinkeigaku 1993; 33 ( 5 ): 477 – 482.; Marey-López J, Rubio-Nazabal E, Alonso-Magdalena L, López-Facal S. Cerebral infarction after toluene inhalation. Cerebrovasc Dis 2003; 16 ( 1 ): 107 – 108. https://doi.org/10.1159/000070128.; Ryu YH, Lee JD, Yoon PH, Jeon P, Kim DI, Shin DW. Cerebral perfusion impairment in a patient with toluene abuse. J Nucl Med 1998; 39 ( 4 ): 632 – 633.; Caldemeyer KS, Armstrong SW, George KK, Moran CC, Pascuzzi RM. The spectrum of neuroimaging abnormalities in solvent abuse and their clinical correlation. J Neuroimaging 1996; 6 ( 3 ): 167 – 173. https://doi.org/10.1111/jon199663167.; Kamran S, Bakshi R. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images. Neuroradiology 1998; 40 ( 8 ): 519 – 521. https://doi.org/10.1007/s002340050637.; Sodeyama N, Orimo S, Okiyama R, Arai M, Tamaki M. A case of chronic thinner intoxication developing hyperkinésie volitionnelle three years after stopping thinner abuse. Rinsho Shinkeigaku 1993; 33 ( 2 ): 213 – 215.; Suzuki Y, Oishi M, Ogawa K, Kamei S. A patient with Marchiafava-Bignami disease as a complication of diabetes mellitus treated effectively with corticosteroid. J Clin Neurosci 2012; 19 ( 5 ): 761 – 762. https://doi.org/10.1016/j.jocn.2011.07.040.; Autti T, Joensuu R, Aberg L. Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 2007; 49 ( 7 ): 571 – 578. https://doi.org/10.1007/s00234-007-0220-6.; Martin A, Sevin C, Lazarus C, Bellesme C, Aubourg P, Adamsbaum C. Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution. AJNR Am J Neuroradiol 2012; 33 ( 9 ): 1731 – 1739. https://doi.org/10.3174/ajnr.A3038.; Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. MRI of brain iron. AJR Am J Roentgenol 1986; 147 ( 1 ): 103 – 110. https://doi.org/10.2214/ajr.147.1.103.; Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI. Magnetic resonance imaging in Parkinson’s disease and parkinsonian syndromes. Neurology 1989; 39 ( 11 ): 1524 – 1526. https://doi.org/10.1212/wnl.39.11.1524.; Chen JC, Hardy PA, Kucharczyk W, et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 1993; 14 ( 2 ): 275 – 281.; Russo C, Smoker WR, Kubal W. Cortical and subcortical T2 shortening in multiple sclerosis. AJNR Am J Neuroradiol 1997; 18 ( 1 ): 124 – 126.; Savoiardo M, Halliday WC, Nardocci N, et al. Hallervorden-Spatz disease: MR and pathologic findings. AJNR Am J Neuroradiol 1993; 14 ( 1 ): 155 – 162.; Albayram S, Ozer H, Gokdemir S, Gulsen F, Kiziltan G, Kocer N, Islak C. Reversible reduction of apparent diffusion coefficient values in bilateral internal capsules in transient hypoglycemia-induced hemiparesis. AJNR Am J Neuroradiol 2006; 27 ( 8 ): 1760 – 1762.; Nakajima N, Ueda M, Nagayama H, Katayama Y. Hypoglycemia-induced spontaneous unilateral jerking movement in bilateral internal capsule posterior limb abnormalities. J Neurol Sci 2014; 338 ( 1–2 ): 220 – 222. https://doi.org/10.1016/j.jns.2013.12.041.; Cousyn L, Law-Ye B, Pyatigorskaya N, et al. Brain MRI features and scoring of leukodystrophy in adult-onset Krabbe disease. Neurology 2019; 93 ( 7 ): e647 – e652. https://doi.org/10.1212/WNL.0000000000007943.; Jin J, Hu F, Zhang Q, Jia R, Dang J. Hyperintensity of the corticospinal tract on FLAIR: a simple and sensitive objective upper motor neuron degeneration marker in clinically verified amyotrophic lateral sclerosis. J Neurol Sci 2016; 367: 177 – 183. https://doi.org/10.1016/j.jns.2016.06.005.; Biswas A, Krishnan P, Amirabadi A, Blaser S, Mercimek-Andrews S, Shroff M. Expanding the neuroimaging phenotype of neuronal ceroid Lipofuscinoses. AJNR Am J Neuroradiol 2020; 41 ( 10 ): 1930 – 1936. https://doi.org/10.3174/ajnr.A6726.; Kriegstein AR, Shungu DC, Millar WS, et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (“chasing the dragon”). Neurology 1999; 53 ( 8 ): 1765 – 1773. https://doi.org/10.1212/wnl.53.8.1765.; Protogerou G, Ralli S, Tsougos I, Patramani I, Hadjigeorgiou G, Fezoulidis I, Kapsalaki EZ. T2 FLAIR increased signal intensity at the posterior limb of the internal capsule: clinical significance in ALS patients. Neuroradiol J 2011; 24 ( 2 ): 226 – 234. https://doi.org/10.1177/197140091102400210.; Herman JS, Chiodini PL. Gnathostomiasis, another emerging imported disease. Clin Microbiol Rev 2009; 22 ( 3 ): 484 – 492. https://doi.org/10.1128/CMR.00003-09.; Sawanyawisuth K, Tiamkao S, Kanpittaya J, Dekumyoy P, Jitpimolmard S. MR imaging findings in cerebrospinal gnathostomiasis. AJNR Am J Neuroradiol 2004; 25 ( 3 ): 446 – 449.; Kanpittaya J, Sawanyawisuth K, Intapan PM, Khotsri P, Chotmongkol V, Maleewong W. A comparative study of neuroimaging features between human neuro-gnathostomiasis and angiostrongyliasis. Neurol Sci 2012; 33 ( 4 ): 893 – 898. https://doi.org/10.1007/s10072-011-0864-1.; Sawanyawisuth K, Tiamkao S, Nitinavakarn B, Dekumyoy P, Jitpimolmard S. MR imaging findings in cauda equina gnathostomiasis. AJNR Am J Neuroradiol 2005; 26 ( 1 ): 39 – 42.; Guillain G. Deux cas de myoclonies synchrones et rythmées vélo-pharyngo-laryngo-oculo-diaphragmatiques. Le problème anatomique et physio-pathologique de ce syndrome. Masson; 1932.; Tilikete C, Desestret V. Hypertrophic olivary degeneration and palatal or oculopalatal tremor. Front Neurol 2017; 8: 302. https://doi.org/10.3389/fneur.2017.00302.; Goyal M, Versnick E, Tuite P, et al. Hypertrophic olivary degeneration: Metaanalysis of the temporal evolution of MR findings. AJNR Am J Neuroradiol 2000; 21 ( 6 ): 1073 – 1077.; Samuel M, Torun N, Tuite PJ, Sharpe JA, Lang AE. Progressive ataxia and palatal tremor (PAPT): clinical and MRI assessment with review of palatal tremors. Brain 2004; 127 ( Pt 6 ): 1252 – 1268. https://doi.org/10.1093/brain/awh137.; Weller PF. Eosinophilic meningitis. Am J Med 1993; 95 ( 3 ): 250 – 253. https://doi.org/10.1016/0002-9343(93)90275-t.; Kanpittaya J, Jitpimolmard S, Tiamkao S, Mairiang E. MR findings of eosinophilic meningoencephalitis attributed to Angiostrongylus cantonensis. AJNR Am J Neuroradiol 2000; 21 ( 6 ): 1090 – 1094.; Rowley HA, Uht RM, Kazacos KR, Sakanari J, Wheaton WV, Barkovich AJ, Bollen AW. Radiologic-pathologic findings in raccoon roundworm (Baylisascaris procyonis) encephalitis. AJNR Am J Neuroradiol 2000; 21 ( 2 ): 415 – 420.; Sánchez SS, García HH, Nicoletti A. Clinical and magnetic resonance imaging findings of Neurotoxocariasis. Front Neurol 2018; 9: 53. https://doi.org/10.3389/fneur.2018.00053.; Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010; 67 ( 4 ): 470 – 478. https://doi.org/10.1002/ana.21917.; Guardado Santervás PL, Arjona Padillo A, Serrano Castro P, et al. Stiff person syndrome (SPS), a basal ganglia disease? Striatal MRI lesions in a patient with SPS. J Neurol Neurosurg Psychiatry 2007; 78 ( 6 ): 657 – 659. https://doi.org/10.1136/jnnp.2006.099705.; Fredriksen JR, Carr CM, Koeller KK, Verdoorn JT, Gadoth A, Pittock SJ, Kotsenas AL. MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy. Neuroradiology 2018; 60 ( 3 ): 239 – 245. https://doi.org/10.1007/s00234-018-1976-6.; Galli JR, Austin SD, Greenlee JE, Clardy SL. Stiff person syndrome with anti-GAD65 antibodies within the national veterans affairs health administration. Muscle Nerve 2018; 58 ( 6 ): 801 – 804. https://doi.org/10.1002/mus.26338.; Gordon CR, Zivotofsky AZ, Siman-Tov T, Gadoth N. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 2007; 68 ( 14 ): 1161; author reply 1161. https://doi.org/10.1212/01.wnl.0000261162.61360.a2.; Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001; 58 ( 2 ): 225 – 230.; Baizabal-Carvallo JF. The neurological syndromes associated with glutamic acid decarboxylase antibodies. J Autoimmun 2019; 101: 35 – 47. https://doi.org/10.1016/j.jaut.2019.04.007.; Hsu YT, Duann JR, Lu MK, Sun MC, Tsai CH. Polyglandular autoimmune syndrome type 4 with GAD antibody and dystonia. Clin Neurol Neurosurg 2012; 114 ( 7 ): 1024 – 1026. https://doi.org/10.1016/j.clineuro.2012.01.051.; Sunwoo JS, Chu K, Byun JI, et al. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders. J Neuroimmunol 2016; 290: 15 – 21. https://doi.org/10.1016/j.jneuroim.2015.11.012.; Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 2006; 81 ( 9 ): 1207 – 1214. https://doi.org/10.4065/81.9.1207.; Jhaveri MD, Salzman KL, Ross JS, Moore KR, Osborn AG, Ho CY. Cerebellar atrophy. Expertddx: Brain and Spine. Second ed. ). ExpertDDx Amsterdam: Elsevier; 2018: 522 – 525. https://doi.org/10.1016/B978-0-323-44308-1.50078-7.; Wijburg MT, van Oosten BW, Murk JL, Karimi O, Killestein J, Wattjes MP. Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature. J Neurol 2015; 262 ( 1 ): 65 – 73. https://doi.org/10.1007/s00415-014-7530-5.; Mekinian A, Tennenbaum J, Lahuna C, et al. Primary Sjögren’s syndrome: central and peripheral nervous system involvements. Clin Exp Rheumatol 2020; 38 Suppl 126 ( 4 ): 103 – 109.; Yerdelen D, Karataş M, Alkan O, Tufan M. A new kind of and reversible brainstem involvement in primary Sjögren’s syndrome as an initial manifestation. Int J Neurosci 2010; 120 ( 2 ): 155 – 158. https://doi.org/10.3109/00207450903359683.; Niu B, Zou Z, Shen Y, Cao B. A case report of Sjögren syndrome manifesting bilateral basal ganglia lesions. Medicine (Baltimore) 2017; 96 ( 17 ): e6715. https://doi.org/10.1097/MD.0000000000006715.; Butryn M, Neumann J, Rolfes L, et al. Clinical, radiological, and laboratory features of spinal cord involvement in primary Sjögren’s syndrome. J Clin Med 2020; 9 ( 5 ): E1482. https://doi.org/10.3390/jcm9051482.; Sakai K, Hamaguchi T, Yamada M. Multiple cranial nerve enhancement on MRI in primary Sjögren’s syndrome. Intern Med 2010; 49 ( 9 ): 857 – 859. https://doi.org/10.2169/internalmedicine.49.3236.; Verma R, Anand R. Limbic encephalitis as a heralding manifestation of primary Sjogren’s syndrome. J Neurosci Rural Pract 2020; 11 ( 4 ): 658 – 660. https://doi.org/10.1055/s-0040-1715997.; Ararat K, Berrios I, Hannoun A, Ionete C. Case of primary Sjogren’s syndrome preceded by dystonia. BMJ Case Rep 2018; 2018: bcr-2017-223468. https://doi.org/10.1136/bcr-2017-223468.; Créange A, Sedel F, Brugières P, Voisin MC, Degos JD. Primary Sjögren’s syndrome presenting as progressive parkinsonian syndrome. Mov Disord 1997; 12 ( 1 ): 121 – 123. https://doi.org/10.1002/mds.870120124.; Kadota Y, Tokumaru AM, Kamakura K, Kohyama S, Okizuka H, Kaji T, Kusano S. Primary Sjögren’s syndrome initially manifested by optic neuritis: MRI findings. Neuroradiology 2002; 44 ( 4 ): 338 – 341. https://doi.org/10.1007/s00234-001-0730-6.; Rabadi MH, Kundi S, Brett D, Padmanabhan R. Neurological pictures. Primary Sjögren syndrome presenting as neuromyelitis optica. J Neurol Neurosurg Psychiatry 2010; 81 ( 2 ): 213 – 214. https://doi.org/10.1136/jnnp.2009.183913.; Wang GQ, Zhang WW. Spontaneous intracranial hemorrhage as an initial manifestation of primary Sjögren’s syndrome: a case report. BMC Neurol 2013; 13: 100. https://doi.org/10.1186/1471-2377-13-100.; Rossi R, Valeria SM. Subacute aseptic meningitis as neurological manifestation of primary Sjögren’s syndrome. Clin Neurol Neurosurg 2006; 108 ( 7 ): 688 – 691. https://doi.org/10.1016/j.clineuro.2005.05.015.; Verma R, Lalla R, Patil TB, Mehta V. Acute myeloneuropathy: An uncommon presentation of Sjögren’s syndrome. Ann Indian Acad Neurol 2013; 16 ( 4 ): 696 – 698. https://doi.org/10.4103/0972-2327.120462.; Sanahuja J, Ordoñez-Palau S, Begué R, Brieva L, Boquet D. Primary Sjögren syndrome with tumefactive central nervous system involvement. AJNR Am J Neuroradiol 2008; 29 ( 10 ): 1878 – 1879. https://doi.org/10.3174/ajnr.A1204.; Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, Stangel M. Longitudinal extensive transverse myelitis—it’s not all neuromyelitis optica. Nat Rev Neurol 2011; 7 ( 12 ): 688 – 698. https://doi.org/10.1038/nrneurol.2011.176.; Stanifer JW, George R, Keenan RT, Massey EW. What started this? Debilitating longitudinally-extensive myelitis. Am J Med 2012; 125 ( 11 ): 1071 – 1073. https://doi.org/10.1016/j.amjmed.2012.07.010.; Fumery T, Baudar C, Ossemann M, London F. Longitudinally extensive transverse myelitis following acute COVID-19 infection. Mult Scler Relat Disord 2021; 48: 102723. https://doi.org/10.1016/j.msard.2020.102723.; Shahriari M, Sotirchos ES, Newsome SD, Yousem DM. MOGAD: how it differs from and resembles other neuroinflammatory disorders. AJR Am J Roentgenol 2021; 216 ( 4 ): 1031 – 1039. https://doi.org/10.2214/AJR.20.24061.; Gopinath M, Nagesh C, Santhosh K, Jayadevan ER. Dementia and parkinsonism-a rare presentation of intracranial dural arteriovenous fistulae. Neurointervention 2017; 12 ( 2 ): 125 – 129. https://doi.org/10.5469/neuroint.2017.12.2.125.; Kwon BJ, Han MH, Kang HS, Chang KH. MR imaging findings of intracranial dural arteriovenous fistulas: relations with venous drainage patterns. AJNR Am J Neuroradiol 2005; 26 ( 10 ): 2500 – 2507.; Pu J, Si X, Ye R, Zhang B. Straight sinus dural arteriovenous fistula presenting with reversible parkinsonism: a case report and literature review. Medicine (Baltimore) 2017; 96 ( 49 ): e9005. https://doi.org/10.1097/MD.0000000000009005.; Chang CW, Hung HC, Tsai JI, Lee PC, Hung SC. Dural arteriovenous fistula with sinus thrombosis and venous reflux presenting as parkinsonism: a case report. Neurologist 2019; 24 ( 4 ): 132 – 135. https://doi.org/10.1097/NRL.0000000000000235.; Velz J, Kulcsar Z, Büchele F, Richter H, Regli L. The challenging clinical Management of Patients with cranial dural arteriovenous fistula and secondary Parkinson’s syndrome: pathophysiology and treatment options. Cerebrovasc Dis Extra 2020; 10 ( 3 ): 124 – 138. https://doi.org/10.1159/000510597.; Luo Y, Qi J, Cen Z, Hu H, Jiang B, Luo W. Two cases of dural arteriovenous fistula presenting with parkinsonism and progressive cognitive dysfunction. J Neurol Sci 2014; 343 ( 1–2 ): 211 – 214. https://doi.org/10.1016/j.jns.2014.05.059.; Lai J, Heran MKS, Stoessl AJ, Gooderham PA. Reversible parkinsonism and rapidly progressive dementia due to Dural arteriovenous fistula: case series and literature review. Mov Disord Clin Pract 2017; 4 ( 4 ): 607 – 611. https://doi.org/10.1002/mdc3.12480.; Enofe I, Thacker I, Shamim S. Dural arteriovenous fistula as a treatable dementia. Proc (Bayl Univ Med Cent) 2017; 30 ( 2 ): 215 – 217. https://doi.org/10.1080/08998280.2017.11929592.; Nogueira RG, Baccin CE, Rabinov JD, Pryor JC, Buonanno FS, Hirsch JA. Reversible parkinsonism after treatment of dural arteriovenous fistula. J Neuroimaging 2009; 19 ( 2 ): 183 – 184. https://doi.org/10.1111/j.1552-6569.2007.00237.x.; Miura S, Noda K, Shiramizu N, et al. Parkinsonism and ataxia associated with an intracranial dural arteriovenous fistula presenting with hyperintense basal ganglia in T1-weighted MRI. J Clin Neurosci 2009; 16 ( 2 ): 341 – 343. https://doi.org/10.1016/j.jocn.2008.01.004.; Nakahara Y, Ogata A, Takase Y, Maeda K, Okamoto H, Matsushima T, Sakata S. Treatment of dural arteriovenous fistula presenting as typical symptoms of hydrocephalus caused by venous congestion: case report. Neurol Med Chir (Tokyo) 2011; 51 ( 3 ): 229 – 232. https://doi.org/10.2176/nmc.51.229.; Fujii T, Yamadori A, Endo K, Suzuki K, Fukatsu R. Disproportionate retrograde amnesia in a patient with herpes simplex encephalitis. Cortex 1999; 35 ( 5 ): 599 – 614.; Osborn AG. Vascular Malformations. Osborn’s Brain. 2nd ed. Amsterdam: Elsevier; 2018.; Zyck S, De Jesus O, Gould GC. Dural Arteriovenous Fistula. Treasure Island (FL): StatPearls. StatPearls Publishing; 2021 Accessed July 12, 2021. http://www.ncbi.nlm.nih.gov/books/NBK532274/.; Ikeda K, Iwasaki Y, Osako M, Ichikawa Y, Kinoshita M. Dural arteriovenous fistula mimicking leukoencephalopathy. Neurology 2000; 54 ( 5 ): 1123. https://doi.org/10.1212/wnl.54.5.1123.; Schievink WI, Tourje J. Intracranial hypotension without meningeal enhancement on magnetic resonance imaging. Case report. J Neurosurg 2000; 92 ( 3 ): 475 – 477. https://doi.org/10.3171/jns.2000.92.3.0475.; Fuh JL, Wang SJ, Lai TH, Hseu SS. The timing of MRI determines the presence or absence of diffuse pachymeningeal enhancement in patients with spontaneous intracranial hypotension. Cephalalgia 2008; 28 ( 4 ): 318 – 322. https://doi.org/10.1111/j.1468-2982.2007.01498.x.; Mokri B. Cerebrospinal fluid volume depletion and its emerging clinical/imaging syndromes. Neurosurg Focus 2000; 9 ( 1 ): e6. https://doi.org/10.3171/foc.2000.9.1.6.; Michali-Stolarska M, Bladowska J, Stolarski M, Sąsiadek MJ. Diagnostic imaging and clinical features of intracranial hypotension—review of literature. Pol J Radiol 2017; 82: 842 – 849. https://doi.org/10.12659/PJR.904433.; Watanabe A, Horikoshi T, Uchida M, Koizumi H, Yamazaki H, Kinouchi H. Subdural effusions in the posterior fossa associated with spontaneous intracranial hypotension. Can J Neurol Sci 2006; 33 ( 2 ): 205 – 208. https://doi.org/10.1017/s0317167100004984.; Zwicker J, Lum C. A treatable mimic of Chiari malformation with syringomyelia. Can J Neurol Sci 2009; 36 ( 4 ): 480 – 482. https://doi.org/10.1017/s0317167100007824.; Mokri B, Ahlskog JE, Luetmer PH. Chorea as a manifestation of spontaneous CSF leak. Neurology 2006; 67 ( 8 ): 1490 – 1491. https://doi.org/10.1212/01.wnl.0000240059.96502.bf.; Mokri B. Movement disorders associated with spontaneous CSF leaks: a case series. Cephalalgia 2014; 34 ( 14 ): 1134 – 1141. https://doi.org/10.1177/0333102414531154.; Wang DJ, Pandey SK, Lee DH, Sharma M. The interpeduncular angle: a practical and objective marker for the detection and diagnosis of intracranial hypotension on brain MRI. AJNR Am J Neuroradiol 2019; 40 ( 8 ): 1299 – 1303. https://doi.org/10.3174/ajnr.A6120.; Figueroa EL, Jog MS, Pelz DM, Lownie SP. Spontaneous intracranial hypotension as a cause of exacerbation in Huntington’s disease. Can J Neurol Sci 2018; 45 ( 3 ): 357 – 359. https://doi.org/10.1017/cjn.2017.296.; Martineau P, Chakraborty S, Faiz K, Shankar J. Imaging of the spontaneous low cerebrospinal fluid pressure headache: a review. Can Assoc Radiol J 2020; 71 ( 2 ): 174 – 185. https://doi.org/10.1177/0846537119888395.; Dobrocky T, Grunder L, Breiding PS, et al. Assessing spinal cerebrospinal fluid leaks in spontaneous intracranial hypotension with a scoring system based on brain magnetic resonance imaging findings. JAMA Neurol 2019; 76 ( 5 ): 580 – 587. https://doi.org/10.1001/jamaneurol.2018.4921.; D’Antona L, Jaime Merchan MA, Vassiliou A, Watkins LD, Davagnanam I, Toma AK, Matharu MS. Clinical presentation, investigation findings, and treatment outcomes of spontaneous intracranial hypotension syndrome: a systematic review and meta-analysis. JAMA Neurol 2021; 78 ( 3 ): 329 – 337. https://doi.org/10.1001/jamaneurol.2020.4799.; Urbach H, Fung C, Dovi-Akue P, Lützen N, Beck J. Spontaneous intracranial hypotension. Dtsch Arztebl Int 2020; 117 ( 27–28 ): 480 – 487. https://doi.org/10.3238/arztebl.2020.0480.; Amrhein TJ, Kranz PG. Spontaneous intracranial hypotension: imaging in diagnosis and treatment. Radiol Clin North Am 2019; 57 ( 2 ): 439 – 451. https://doi.org/10.1016/j.rcl.2018.10.004.; Alcaide-Leon P, López-Rueda A, Coblentz A, Kucharczyk W, Bharatha A, de Tilly LN. Prominent inferior Intercavernous sinus on sagittal T1-weighted images: a sign of intracranial hypotension. AJR Am J Roentgenol 2016; 206 ( 4 ): 817 – 822. https://doi.org/10.2214/AJR.15.14872.; Kranz PG, Gray L, Malinzak MD, Amrhein TJ. Spontaneous intracranial hypotension: pathogenesis, diagnosis, and treatment. Neuroimaging Clin N Am 2019; 29 ( 4 ): 581 – 594. https://doi.org/10.1016/j.nic.2019.07.006.; Antony J, Hacking C, Jeffree RL. Pachymeningeal enhancement-a comprehensive review of literature. Neurosurg Rev 2015; 38 ( 4 ): 649 – 659. https://doi.org/10.1007/s10143-015-0646-y.; Hatano T, Kubo SI, Hattori N, Mizuno Y. Movement disorders in neoplastic brain disease. Movement Disorders in Neurologic and Systemic Disease. Cambridge, UK: Cambridge University Press; 2014: 279 – 299.; Broski SM, Hunt CH, Johnson GB, Morreale RF, Lowe VJ, Peller PJ. Structural and functional imaging in parkinsonian syndromes. Radiographics 2014; 34 ( 5 ): 1273 – 1292. https://doi.org/10.1148/rg.345140009.; Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003; 210 ( 1–2 ): 57 – 60. https://doi.org/10.1016/s0022-510x(03)00014-5.; Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64 ( 12 ): 2050 – 2055. https://doi.org/10.1212/01.WNL.0000165960.04422.D0.; Adachi M, Kawanami T, Ohshima H, Sugai Y, Hosoya T. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci 2004; 3 ( 3 ): 125 – 132. https://doi.org/10.2463/mrms.3.125.; Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, Dickson DW. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003; 60 ( 11 ): 1766 – 1769. https://doi.org/10.1212/01.wnl.0000068011.21396.f4.; Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 2017; 32 ( 6 ): 853 – 864. https://doi.org/10.1002/mds.26987.; Villano JL, Propp JM, Porter KR, et al. Malignant pineal germ-cell tumors: an analysis of cases from three tumor registries. Neuro Oncol 2008; 10 ( 2 ): 121 – 130. https://doi.org/10.1215/15228517-2007-054.; Al-Hussaini M, Sultan I, Abuirmileh N, Jaradat I, Qaddoumi I. Pineal gland tumors: experience from the SEER database. J Neurooncol 2009; 94 ( 3 ): 351 – 358. https://doi.org/10.1007/s11060-009-9881-9.; Averbuch-Heller L, Paulson GW, Daroff RB, Leigh RJ. Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry 1999; 66 ( 4 ): 532 – 535. https://doi.org/10.1136/jnnp.66.4.532.; Sharma OP, Sharma AM. Sarcoidosis of the nervous system. A clinical approach. Arch Intern Med 1991; 151 ( 7 ): 1317 – 1321.

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal